# A Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in Adults

> **NCT04031040** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Nyxoah S.A.** · enrollment: 110 (estimated)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DEVICE:** Genio® system therapy

## Key facts

- **NCT ID:** NCT04031040
- **Lead sponsor:** Nyxoah S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-09-01
- **Primary completion:** 2026-10-30
- **Final completion:** 2030-10
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04031040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04031040, "A Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in Adults". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04031040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*